Symons Capital Management Inc. trimmed its stake in shares of Clorox Co (NYSE:CLX) by 10.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 53,106 shares of the company’s stock after selling 6,098 shares during the period. Clorox accounts for 3.7% of Symons Capital Management Inc.’s holdings, making the stock its 6th biggest position. Symons Capital Management Inc.’s holdings in Clorox were worth $8,065,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds also recently bought and sold shares of the company. Tower View Investment Management & Research LLC lifted its stake in shares of Clorox by 19.4% in the second quarter. Tower View Investment Management & Research LLC now owns 387 shares of the company’s stock worth $59,000 after buying an additional 63 shares in the last quarter. World Asset Management Inc lifted its stake in shares of Clorox by 0.7% in the second quarter. World Asset Management Inc now owns 9,872 shares of the company’s stock worth $1,512,000 after buying an additional 65 shares in the last quarter. Nvwm LLC raised its stake in Clorox by 1.7% during the third quarter. Nvwm LLC now owns 4,248 shares of the company’s stock worth $645,000 after purchasing an additional 71 shares during the period. Arrow Financial Corp raised its stake in Clorox by 9.2% during the second quarter. Arrow Financial Corp now owns 892 shares of the company’s stock worth $137,000 after purchasing an additional 75 shares during the period. Finally, Cypress Capital Group raised its stake in Clorox by 1.8% during the second quarter. Cypress Capital Group now owns 4,312 shares of the company’s stock worth $660,000 after purchasing an additional 75 shares during the period. 78.42% of the stock is currently owned by institutional investors and hedge funds.
In other Clorox news, SVP Michael R. Costello sold 6,997 shares of Clorox stock in a transaction dated Wednesday, September 4th. The shares were sold at an average price of $162.56, for a total transaction of $1,137,432.32. Following the completion of the sale, the senior vice president now directly owns 29,016 shares in the company, valued at $4,716,840.96. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Andrew J. Mowery sold 5,648 shares of Clorox stock in a transaction dated Monday, November 4th. The shares were sold at an average price of $146.29, for a total transaction of $826,245.92. Following the sale, the senior vice president now owns 15,920 shares of the company’s stock, valued at $2,328,936.80. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 15,870 shares of company stock valued at $2,484,000. Company insiders own 1.14% of the company’s stock.
A number of equities analysts have commented on CLX shares. Barclays set a $138.00 target price on shares of Clorox and gave the stock a “sell” rating in a research note on Friday, November 1st. Wells Fargo & Co reaffirmed a “hold” rating and set a $150.00 target price on shares of Clorox in a research note on Wednesday, October 2nd. Zacks Investment Research raised shares of Clorox from a “sell” rating to a “hold” rating and set a $175.00 target price on the stock in a research note on Monday, July 29th. Bank of America reduced their target price on shares of Clorox from $165.00 to $160.00 and set a “neutral” rating on the stock in a research note on Thursday, October 3rd. Finally, UBS Group reduced their target price on shares of Clorox from $128.00 to $125.00 and set a “sell” rating on the stock in a research note on Thursday, October 3rd. Five equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have issued a buy rating to the stock. Clorox presently has an average rating of “Hold” and a consensus target price of $152.00.
Shares of CLX traded up $0.98 during trading on Friday, reaching $148.00. 639,305 shares of the company traded hands, compared to its average volume of 896,025. Clorox Co has a twelve month low of $143.58 and a twelve month high of $167.70. The stock has a market cap of $18.55 billion, a PE ratio of 23.42, a price-to-earnings-growth ratio of 4.73 and a beta of 0.38. The stock has a 50-day simple moving average of $149.93 and a 200-day simple moving average of $154.33. The company has a quick ratio of 0.52, a current ratio of 0.87 and a debt-to-equity ratio of 4.69.
Clorox (NYSE:CLX) last announced its quarterly earnings results on Thursday, October 31st. The company reported $1.59 earnings per share for the quarter, beating analysts’ consensus estimates of $1.54 by $0.05. Clorox had a net margin of 13.20% and a return on equity of 123.56%. The business had revenue of $1.51 billion during the quarter, compared to analysts’ expectations of $1.51 billion. During the same period last year, the business earned $1.62 earnings per share. The business’s revenue for the quarter was down 3.6% on a year-over-year basis. On average, equities research analysts predict that Clorox Co will post 6.16 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Wednesday, October 30th will be given a dividend of $1.06 per share. This represents a $4.24 dividend on an annualized basis and a dividend yield of 2.86%. The ex-dividend date of this dividend is Tuesday, October 29th. Clorox’s dividend payout ratio is presently 67.09%.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Featured Story: Technical Analysis of Stocks, How Can It Help
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.